CTRI/2022/06/042980
Not yet recruiting
未知
Medication adherence and management of risk factors for secondary prevention of stroke using smart phone- based application: A feasibility study
World Stroke Organization0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: I63- Cerebral infarction
- Sponsor
- World Stroke Organization
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Adult ( \>18 years) patients with onset of stroke within 1 month.
- •2\.Severity :\- mRs \<5
- •3\.Presence of one or more vascular risk factors such as hypertension, diabetes mellitus, smoking and dyslipidemia.
- •4\.Patient/caregivers who could fully understand the use of an Android\-based smartphone.
Exclusion Criteria
- •1\.Patients with severe disability \-modified Rankin Scale score \>4
- •2\.Patients who do not consent.
- •3\.Severe cognitive impairment.
- •4\.Stroke survivor without a primary caregiver.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Medication adherence and management of risk factors for secondary stroke preventioISRCTN31718066World Stroke Organization208
Completed
Not Applicable
Medication adherence and continuity of care (Observational study of impact of medication adherence on renal function in comorbid patients with type 2 diabetes and depression)Diabetes and depressionJPRN-UMIN000017513ational Center of Neurology and Psychiatry550
Recruiting
Not Applicable
Effect of a pharmacotherapeutic management protocol in patients hospitalized with cardiovascular diseasesRBR-26ydc3Alfredo Dias de Oliveira Filho
Not yet recruiting
Not Applicable
to study the medication adherence of anti-HIV medicines in people living with HIV/AIDSCTRI/2023/03/051142GGS Medical college and Hospital
Not yet recruiting
Not Applicable
A clinical trial to study the treatment characteristics and key factors in patients receiving maintained dialysis treatmentHealth Condition 1: N186- End stage renal diseaseCTRI/2022/11/047203RHEMA SUSAN VARGHESE